(Q40171279)

English

Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

scientific article published on 13 February 2007

Statements

Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia (English)
0 references
0 references
0 references
0 references
Jelena V Jovanovic
Katherine Waghorn
Finella Brito-Babapulle
Rüdiger Hehlmann
Nicholas C P Cross
Andreas Reiter
David Grimwade

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit